Fidelity International’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Sell
140,889
-19,237
-12% -$1.84M 0.01% 562
2025
Q4
$15.4M Buy
160,126
+6,524
+4% +$634K 0.01% 516
2025
Q3
$14.6M Buy
153,602
+145,163
+1,720% +$13.3M 0.01% 519
2025
Q2
$736K Buy
8,439
+3,777
+81% +$320K ﹤0.01% 768
2025
Q1
$419K Sell
4,662
-752
-14% -$67.3K ﹤0.01% 797
2024
Q4
$432K Buy
5,414
+748
+16% +$64.8K ﹤0.01% 796
2024
Q3
$420K Sell
4,666
-42,738
-90% -$3.6M ﹤0.01% 792
2024
Q2
$3.73M Buy
47,404
+43,091
+999% +$3.53M ﹤0.01% 632
2024
Q1
$376K Buy
4,313
+904
+27% +$77.2K ﹤0.01% 777
2023
Q4
$281K Buy
+3,409
New +$260K ﹤0.01% 756
2021
Q3
Sell
-12,280
Closed -$1.52M 868
2021
Q2
$1.52M Sell
12,280
-10,621
-46% -$1.33M ﹤0.01% 719
2021
Q1
$2.71M Buy
22,901
+21,216
+1,259% +$2.49M ﹤0.01% 656
2020
Q4
$197K Buy
1,685
+1,447
+608% +$159K ﹤0.01% 723
2020
Q3
$24K Sell
238
-337
-59% -$33.8K ﹤0.01% 720
2020
Q2
$53K Sell
575
-714,286
-100% -$68.5M ﹤0.01% 682
2020
Q1
$64.5M Sell
714,861
-1,868,983
-72% -$199M 0.11% 193
2019
Q4
$293M Buy
2,583,844
+383,843
+17% +$42.1M 0.41% 58
2019
Q3
$239M Buy
2,200,001
+1,841,531
+514% +$192M 0.36% 62
2019
Q2
$34.9M Sell
358,470
-280,183
-44% -$25.6M 0.05% 300
2019
Q1
$58.2M Buy
638,653
+10,905
+2% +$976K 0.09% 218
2018
Q4
$57.1M Buy
627,748
+311,667
+99% +$29.1M 0.1% 207
2018
Q3
$31.1M Buy
316,081
+129,050
+69% +$11.9M 0.05% 334
2018
Q2
$16M Buy
187,031
+52,021
+39% +$4.35M 0.02% 427
2018
Q1
$10.8M Sell
135,010
-378,943
-74% -$31.3M 0.03% 344
2017
Q4
$41.5M Buy
513,953
+1,135
+0.2% +$90.9K 0.12% 186
2017
Q3
$39.9M Sell
512,818
-35,012
-6% -$2.91M 0.11% 171
2017
Q2
$48.6M Sell
547,830
-50,968
-9% -$4.3M 0.14% 155
2017
Q1
$48.2M Sell
598,798
-61,427
-9% -$4.8M 0.14% 162
2016
Q4
$47M Sell
660,225
-407,011
-38% -$32M 0.14% 155
2016
Q3
$92.2M Sell
1,067,236
-296,723
-22% -$25.9M 0.28% 92
2016
Q2
$118M Sell
1,363,959
-1,049,879
-43% -$84.9M 0.38% 73
2016
Q1
$181M Buy
2,413,838
+61,260
+3% +$4.61M 0.56% 54
2015
Q4
$181M Buy
2,352,578
+410,366
+21% +$30.9M 0.55% 53
2015
Q3
$130M Buy
1,942,212
+788,105
+68% +$58M 0.45% 65
2015
Q2
$85.5M Sell
1,154,107
-454,995
-28% -$34.8M 0.27% 96
2015
Q1
$125M Buy
1,609,102
+61,568
+4% +$4.67M 0.4% 78
2014
Q4
$112M Sell
1,547,534
-308,381
-17% -$21.4M 0.39% 79
2014
Q3
$115M Sell
1,855,915
-274,507
-13% -$17.5M 0.44% 65
2014
Q2
$136M Sell
2,130,422
-162,870
-7% -$9.89M 0.51% 58
2014
Q1
$141M Buy
2,293,292
+353,953
+18% +$20.6M 0.51% 52
2013
Q4
$111M Buy
1,939,339
+410,289
+27% +$23.3M 0.45% 68
2013
Q3
$81.4M Buy
1,529,050
+120,796
+9% +$6.5M 0.39% 71
2013
Q2
$72.5M Buy
+1,408,254
New +$69.6M 0.41% 69

Other funds holding MDT

Fidelity International's MDT Position: Q1 2026 in Review

Fidelity International reduced its Medtronic (MDT) stake by 12% in Q1 2026, selling an estimated $1.84M and leaving 140,889 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #562.

Fidelity International first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $293M in Q4 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Fidelity International held 140,889 shares of Medtronic worth $12.2M as of Q1 2026.
  • Fidelity International sold 19,237 Medtronic shares in Q1 2026, an estimated $1.84M.
  • Medtronic made up 0.01% of Fidelity International's portfolio in Q1 2026, its #562 holding.
  • Fidelity International first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
  • Fidelity International's Medtronic position peaked at $293M in Q4 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.